Published in Br J Ophthalmol on March 01, 1998
Is screening for interferon retinopathy in hepatitis C justified? Br J Ophthalmol (2004) 1.37
Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin. Br J Ophthalmol (2001) 1.19
Depression following pegylated interferon-alpha: characteristics and vulnerability. J Psychosom Res (2007) 1.16
Pegylated interferon alpha-associated optic neuropathy. J Neuroophthalmol (2010) 1.06
Severe interferon associated retinopathy. Br J Ophthalmol (2003) 0.92
Pegylated interferon-associated severe retinopathy in a patient with chronic hepatitis. Korean J Ophthalmol (2012) 0.86
Interferon-alpha-associated presumed ocular sarcoidosis. Graefes Arch Clin Exp Ophthalmol (2008) 0.81
Ischemic optic neuropathy associated with low-dose interferon alfa: report of two cases. Am J Clin Oncol (2009) 0.80
Cystoid macular edema and visual loss as sequelae to interferon alpha treatment of systemic hepatitis C. Indian J Ophthalmol (2010) 0.80
Outcome of retinopathy in chronic hepatitis C patients treated with peginterferon and ribavirin. Dig Dis Sci (2009) 0.79
[Combined retinal artery and vein occlusions associated with interferon beta therapy]. Ophthalmologe (2012) 0.77
Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature. J Neurol (2015) 0.77
Effect of in vitro interferon-beta administration on hepatitis C virus in peripheral blood mononuclear cells as a predictive marker of clinical response to interferon treatment for chronic hepatitis C. World J Gastroenterol (2004) 0.76
Retinopathy associated with adjuvant high-dose interferon-α2b in a patient with resected melanoma: a case report and review of the literature. Oncologist (2012) 0.75
Retinopathy associated with interferon therapy in patients with hepatitis C virus. Clin Ophthalmol (2012) 0.75
Impending anterior ischemic optic neuropathy with elements of retinal vein occlusion in a patient on interferon for polycythemia vera. Clin Ophthalmol (2012) 0.75
The efficacy of intravitreal interferon alpha-2b for the treatment of experimental endotoxin-induced uveitis. Indian J Ophthalmol (2016) 0.75
Bilateral juxtapapillary choroidal neovascularisation associated with interferon alfa treatment of a metastatic cutaneous melanoma. Br J Ophthalmol (2006) 0.75
Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci (1957) 13.46
Interferon-associated retinopathy. Arch Ophthalmol (1993) 2.73
Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration. Ophthalmology (1993) 2.02
Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med (1989) 1.85
Inhibition of endothelial cell proliferation by gamma-interferon. J Cell Biol (1987) 1.72
Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol (1986) 1.50
Clinical characteristics of hepatitis C virus-associated retinopathy. Jpn J Ophthalmol (1995) 1.42
Oculomotor nerve paralysis induced by alpha II-interferon. Acta Neurol Belg (1990) 1.27
Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa. Br J Ophthalmol (1995) 1.26
Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology (1993) 1.26
Interferon alpha 2a for treatment of age-related macular degeneration. Am J Ophthalmol (1991) 1.25
[Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis]. Nippon Ganka Gakkai Zasshi (1996) 1.19
Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. J Clin Oncol (1985) 1.07
[Interferon-induced retinal changes]. Nippon Ganka Gakkai Zasshi (1994) 0.97
Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1978) 0.91
Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma. Oncology (1989) 0.85
Local interferon alfa-2b for ocular cicatricial pemphigoid. Br J Ophthalmol (1996) 0.82
Toxicity of intravitreal interferon. Ophthalmic Surg (1986) 0.82
Recombinant leukocyte A interferon in Kaposi's sarcoma. Ann N Y Acad Sci (1984) 0.81
The sequence of the human genome. Science (2001) 101.55
A Toll-like receptor recognizes bacterial DNA. Nature (2000) 26.34
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity (1998) 18.12
HTLV-I associated myelopathy, a new clinical entity. Lancet (1986) 10.49
Activation tagging in Arabidopsis. Plant Physiol (2000) 7.09
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A (1997) 7.08
Essential role of Stat6 in IL-4 signalling. Nature (1996) 6.56
A thermostable sequence-specific endonuclease from Thermus aquaticus. Proc Natl Acad Sci U S A (1977) 5.79
Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J (2000) 5.61
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol (2001) 5.27
Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti. DNA Res (2000) 4.94
Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci U S A (2000) 4.41
The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev (1998) 4.29
Complete genomic sequence of the filamentous nitrogen-fixing cyanobacterium Anabaena sp. strain PCC 7120. DNA Res (2001) 4.27
Endoscopic papillary balloon dilation for the management of common bile duct stones: experience of 226 cases. Endoscopy (1998) 4.11
Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol (2000) 4.10
Cloning of a Streptococcus mutans glucosyltransferase gene coding for insoluble glucan synthesis. Infect Immun (1986) 4.08
Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology (1990) 3.91
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Safety and cognitive effect of frontal DC brain polarization in healthy individuals. Neurology (2005) 3.74
U box proteins as a new family of ubiquitin-protein ligases. J Biol Chem (2001) 3.70
Discovery of a cool planet of 5.5 Earth masses through gravitational microlensing. Nature (2006) 3.53
Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci U S A (2001) 3.49
An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J (1999) 3.42
Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol (1987) 2.99
Language dominance in partial epilepsy patients identified with an fMRI reading task. Neurology (2002) 2.98
Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem (1983) 2.97
Production of large amounts of antibodies in individual mice. J Immunol (1976) 2.93
IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Int Immunol (1999) 2.84
Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol (1997) 2.79
Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology (2005) 2.77
Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology (2004) 2.76
'Ischemic tolerance' phenomenon found in the brain. Brain Res (1990) 2.73
Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity (1995) 2.69
STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci U S A (1996) 2.64
Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol Cell Biol (1998) 2.59
ARR1, a transcription factor for genes immediately responsive to cytokinins. Science (2001) 2.50
The secondarily generalized tonic-clonic seizure: a videotape analysis. Neurology (1994) 2.50
Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J Biol Chem (2001) 2.45
PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet (1997) 2.44
Episome-mediated Transfer of Drug Resistance in Enterobacteriaceae X. Restriction and Modification of Phages by fi R Factors. J Bacteriol (1966) 2.43
Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci (1998) 2.39
Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke (1998) 2.34
A large scale analysis of cDNA in Arabidopsis thaliana: generation of 12,028 non-redundant expressed sequence tags from normalized and size-selected cDNA libraries. DNA Res (2000) 2.33
Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol Cell Biol (1998) 2.32
Motoneuron-disease-like disorder after ganglioside therapy. Lancet (1991) 2.30
Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol (1998) 2.28
Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol (1991) 2.27
Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology (2010) 2.24
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity (2000) 2.16
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Conjunction search revisited. J Exp Psychol Hum Percept Perform (1990) 2.15
Body mass index in male patients with COPD: correlation with low attenuation areas on CT. Thorax (2008) 2.12
Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors. Infect Immun (2000) 2.10
Discovery of a Jupiter/Saturn analog with gravitational microlensing. Science (2008) 2.09
Substrate recognition by ADAR1 and ADAR2. RNA (2001) 2.09
Initial events of myelination involve Fyn tyrosine kinase signalling. Nature (1994) 2.08
Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc Natl Acad Sci U S A (1999) 2.04
Six family genes--structure and function as transcription factors and their roles in development. Bioessays (2000) 2.03
Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation (1989) 2.01
The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity (1997) 2.00
A DNA methylase from Thermus thermophilus HB8. J Biochem (1980) 2.00
Lymphotoxin-alpha (LTalpha) supports development of splenic follicular structure that is required for IgG responses. J Exp Med (1997) 1.99
CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu Rev Immunol (1997) 1.99
Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care (1992) 1.97
Role of the putative membrane-bound endo-1,4-beta-glucanase KORRIGAN in cell elongation and cellulose synthesis in Arabidopsis thaliana. Plant Cell Physiol (2001) 1.97
Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. Mol Cell Biol (1999) 1.96
Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology (1993) 1.96
The AHK4 gene involved in the cytokinin-signaling pathway as a direct receptor molecule in Arabidopsis thaliana. Plant Cell Physiol (2001) 1.94
Lingual and buccal mandibular bone depressions: a review based on 583 cases from a world-wide literature survey, including 69 new cases from Japan. Dentomaxillofac Radiol (2002) 1.93
Overexpression of an Arabidopsis thaliana high-affinity phosphate transporter gene in tobacco cultured cells enhances cell growth under phosphate-limited conditions. Proc Natl Acad Sci U S A (1997) 1.91
Possible relationship of a 36-megadalton Salmonella enteritidis plasmid to virulence in mice. Infect Immun (1985) 1.91
A large scale structural analysis of cDNAs in a unicellular green alga, Chlamydomonas reinhardtii. I. Generation of 3433 non-redundant expressed sequence tags. DNA Res (1999) 1.90
Atypical language in lesional and nonlesional complex partial epilepsy. Neurology (2007) 1.88
ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. Mol Cell Biol (1998) 1.88
Resistance of Fc receptor- deficient mice to fatal glomerulonephritis. J Clin Invest (1998) 1.88
Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells (1996) 1.86
Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. J Immunol (1990) 1.86
High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol (1998) 1.86
Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS). Diabetologia (2009) 1.85
Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science (2001) 1.84
Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology (2000) 1.83
Cross-cultural comparison of the sleep-disordered breathing prevalence among Americans and Japanese. Eur Respir J (2010) 1.79
The amino acid sequences of erabutoxins, neurotoxic proteins of sea-snake (Laticauda semifasciata) venom. Biochem J (1971) 1.79
A new immunologic marker for human Langerhans cells. N Engl J Med (1981) 1.79
Production of a monoclonal antibody useful in the molecular characterization of murine T-cell-replacing factor/B-cell growth factor II. Proc Natl Acad Sci U S A (1987) 1.79
Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol (1996) 1.79
Primary hepatic lymphoma associated with primary biliary cirrhosis. Am J Gastroenterol (1999) 1.77